Business
Press Release Sep 16 2022
Zydus Lifesciences Limited has informed the Exchange about press release dated 16-Sep-2022 titled Zydus receives tentative approval from the USFDA for Sugammadex Injection
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange about press release dated 16-Sep-2022 titled Zydus receives tentative approval from the USFDA for Sugammadex Injection View Attachment","length":327,"tagName":"div"}]